In today's Pharmalittle roundup, we're reading about HHS canceling a Moderna contract, FDA rejecting a rare disease drug, and ...

WINNIPEG, Manitoba, May 29, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) ("Kane Biotech”, "Kane” or the "Company”) ...

Spero Therapeutics, Inc. (NASDAQ:SPRO) saw its stock surge by 240% on May 28 following the company’s announcement of the ...

Clinigen has entered a new phase of collaboration with Japanese drugmaker Shionogi (TYO: 4507), signing a licensing agreement ...

Innovation-led resilient livestock sector will not only strengthen the country’s rural economy but also serve as a model for ...

AI is reshaping labs and Clever Culture’s tech is gaining Big Pharma attention as diagnostics and cleanrooms go digital.

In 2025, the global proteose peptone market is anticipated to be worth USD 151.4 million, with projections indicating a rise ...

BRANFORD, CT, USA I May 28, 2025 I Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies ...

Spero Therapeutics (Nasdaq: SPRO) is making headlines as its stock experienced a remarkable 244% surge to $2.35 yesterday, on news of positive clinical trial results.

Shares of Spero Therapeutics SPRO more than tripled in market value yesterday after a phase III study evaluating its ...

Probiotic Supplements Market The Probiotic Supplements Market is experiencing steady growth, driven by rising consumer awareness of gut hea ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...